Implications of Clinical Trial Design on Sample Size Requirements

Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4

Abstract

The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison groups reduce the risk of bias. The design must also provide sufficient statistical power to detect a clinically meaningful treatment effect and maintain a nominal level of type I error. An attempt to integrate neurocognitive science into an RCT poses additional challenges. Two particularly relevant aspects of such a design often receive insufficient attention in an RCT. Multiple outcomes inflate type I error, and an unreliable assessment process introduces bias and reduces statistical power. Here we describe how both unreliability and multiple outcomes can increase the study costs and duration and reduce the feasibility of the study. The objective of this article is to consider strategies that overcome the problems of unreliability and multiplicity.

Authors and Affiliations

Andrew C. Leon

Keywords

Related Articles

Implications of Clinical Trial Design on Sample Size Requirements

The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison group...

Theory of Mind and Schizophrenia: A Positron Emission Tomography Study of Medication-Free Patients

Background: “Theory of mind” (TOM) refers to the ability to attribute mental states (ie, beliefs and goals) to one's self and others and to recognize that behaviors are guided by these mental states. This...

Abnormal Superior Temporal Connectivity During Fear Perception in Schizophrenia

Patients with schizophrenia have difficulty in decoding facial affect. A study using event–related functional neuroimaging indicated that errors in fear detection in schizophrenia are associated with paradoxicall...

Structural Cerebral Variations as Useful Endophenotypes in Schizophrenia: Do They Help Construct “Extended Endophenotypes”?

Endophenotypes represent intermediate phenotypes on the putative causal pathway from the genotype to the phenotype. They offer a potentially valuable strategy to examine the molecular etiopathology of complex behavioral...

Neurophysiological Endophenotypes Across Bipolar and Schizophrenia Psychosis

The search for liability genes of the world's 2 major psychotic disorders, schizophrenia and bipolar disorder I (BP-I), has been extremely difficult even though evidence suggests that both are highly heritable. This diff...

Download PDF file
  • EP ID EP683278
  • DOI  10.1093/schbul/sbn035
  • Views 89
  • Downloads 0

How To Cite

Andrew C. Leon (). Implications of Clinical Trial Design on Sample Size Requirements. Schizophrenia Bulletin, 34(4), -. https://europub.co.uk/articles/-A-683278